Longeveron (LGVN) Interest Expenses (2020 - 2022)
Longeveron (LGVN) recorded quarterly Interest Expenses of $1.4 million in Q4 2022, up 139600.0% quarter-over-quarter from $1000.0 in Q4 2021, and up 139600.0% on a YoY basis from N/an in Q4 2021.
Longeveron (LGVN) Interest Expenses (2020 - 2022) Analysis & Trends
Longeveron's Interest Expenses history runs 3 years deep, the most recent figure standing at $1.4 million for Q4 2022.
- In Q4 2022, Interest Expenses rose 139600.0% year-over-year to $1.4 million; the TTM figure through Sep 2023 stood at $1.4 million (up 139600.0% YoY), while the FY2022 annual figure was $1.4 million, up 34850.0% from the prior year.
- Interest Expenses was $1.4 million for Q4 2022 at Longeveron, up from $1000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.4 million in Q4 2022 to a low of $1000.0 in Q3 2021.
- Historically, Interest Expenses has averaged $234666.7 across 3 years, with a median of $2500.0 in 2020.
- The sharpest annual moves came in 2021 and 2022: Interest Expenses sank 75.0% in 2021, then soared 139600.0% in 2022.
- A 3-year view of Interest Expenses shows it stood at $3000.0 in 2020, then tumbled by 66.67% to $1000.0 in 2021, then jumped by 139600.0% to $1.4 million in 2022.
- The last three Interest Expenses figures came in at $1.4 million (Q4 2022), $1000.0 (Q4 2021), and $1000.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.40 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |